
	Journal of Biological Sciences
	Year: 2013 \| Volume: 13 \| Issue: 8 \| Page No.: 727-731 DOI: 10.3923/jbs.2013.727.731

Studying the Treatment Effects of Erythromycin in Patients Suffering from Pityriasis Rosea

Hamideh Azimi, Effat Khodaeiani and Mohamad Goldust

Abstract: This study aimed at evaluating the efficacy of oral erythromycin in patients with Pityriasis Rosea. Fifty patients were selected which were the divided into 2 groups. In group A (test group) the patients were treated by erythromycin while in group B (plecebo group) the patients received chlorpheniramin or diphenhydramin. Complete response was observed in 16 patients (64%) in the treatment group (A) and none in the second group (B) (p = 0/0001). It is recommended to treat the patients suffering from pityriasis rosea at any time of disease diagnosis using oral erythromycin for a two-week period.

PDF Fulltext XML References Citation Report Citation

RELATED ARTICLES:

•	IgG Antibodies in Patients with Pemphigus Vulgaris before and after Diagnosing with Immunofluorescence

•	Evaluation of Magnetic Resonance Imaging Signal Changes in Vertebral Depressed Fractures to Determine the Fracture Time

•	Complications in Premature Labor Between Severe Preeclampsia and Normal Pregnancies

•	Serum Iron and Ferritin Level in Idiopathic Parkinson

How to cite this article:

Hamideh Azimi, Effat Khodaeiani and Mohamad Goldust, 2013. Studying the Treatment Effects of Erythromycin in Patients Suffering from Pityriasis Rosea. Journal of Biological Sciences, 13: 727-731.

DOI: 10.3923/jbs.2013.727.731

URL: https://scialert.net/abstract/?doi=jbs.2013.727.731

COMMENT ON THIS PAPER

Navigation


		Online First
		Current Issue
		Previous Issues
		Editorial Board
		Submit a Manuscript
		Guide to Authors
		Subscribe to E-alerts

Indexed In


		AGRICOLA
		AGRIS
		ASCI-Database
		Asian Digital Library
		Cambridge Scientific Abstract
		EMBASE
		Google Scholar
		SCIMAGO

Science Alert